Special items: Ovarian Cancer and Us blog best viewed in Firefox

Monday, June 28, 2010

abstract: Clinical Biochemistry : Nidogen-2: A new serum biomarker for ovarian cancer (multinational study)

Conclusions:
Nidogen-2 is a new biomarker for ovarian cancer which correlates closely with CA125.

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.